Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China.
State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Adv Sci (Weinh). 2024 Jul;11(25):e2401583. doi: 10.1002/advs.202401583. Epub 2024 Apr 24.
The nonselective calcium-permeable Transient Receptor Potential Cation Channel Subfamily V Member4 (TRPV4) channel regulates various physiological activities. Dysfunction of TRPV4 is linked to many severe diseases, including edema, pain, gastrointestinal disorders, lung diseases, and inherited neurodegeneration. Emerging TRPV4 antagonists show potential clinical benefits. However, the molecular mechanisms of TRPV4 antagonism remain poorly understood. Here, cryo-electron microscopy (cryo-EM) structures of human TRPV4 are presented in-complex with two potent antagonists, revealing the detailed binding pockets and regulatory mechanisms of TRPV4 gating. Both antagonists bind to the voltage-sensing-like domain (VSLD) and stabilize the channel in closed states. These two antagonists induce TRPV4 to undergo an apparent fourfold to twofold symmetry transition. Moreover, it is demonstrated that one of the antagonists binds to the VSLD extended pocket, which differs from the canonical VSLD pocket. Complemented with functional and molecular dynamics simulation results, this study provides crucial mechanistic insights into TRPV4 regulation by small-molecule antagonists, which may facilitate future drug discovery targeting TRPV4.
非选择性钙通透瞬时受体电位阳离子通道亚家族 V 成员 4(TRPV4)通道调节各种生理活动。TRPV4 功能障碍与许多严重疾病有关,包括水肿、疼痛、胃肠道疾病、肺部疾病和遗传性神经退行性疾病。新兴的 TRPV4 拮抗剂显示出潜在的临床益处。然而,TRPV4 拮抗作用的分子机制仍知之甚少。在这里,展示了与人 TRPV4 复合物的两种有效拮抗剂的低温电子显微镜(cryo-EM)结构,揭示了 TRPV4 门控的详细结合口袋和调节机制。两种拮抗剂都结合到电压感应样结构域(VSLD)并将通道稳定在关闭状态。这两种拮抗剂诱导 TRPV4 发生明显的四到二倍对称转变。此外,还证明了一种拮抗剂结合到 VSLD 扩展口袋,这与典型的 VSLD 口袋不同。结合功能和分子动力学模拟结果,这项研究为小分子拮抗剂对 TRPV4 的调节提供了重要的机制见解,这可能有助于未来针对 TRPV4 的药物发现。